SCHEMBL20060467

SCHEMBL20060467

CCCCCC[B-](c1ccc(-c2ccccc2)cc1)(c1ccc(-c2ccccc2)cc1)c1ccc(-c2ccccc2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MGLL Q99685 1/20 0.43
MMP2 P08253 2/20 0.42
MMP9 P14780 2/20 0.42
POLB P06746 1/20 0.40
HSD11B1 P28845 1/20 0.39
MEN1 O00255 2/20 0.38
MAPT P10636 2/20 0.38
KMT2A Q03164 2/20 0.38
TP53 P04637 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
HPGD P15428 2/20 0.38
GAA P10253 1/20 0.38
HDAC3 O15379 1/20 0.38
HDAC1 Q13547 1/20 0.38
HDAC2 Q92769 1/20 0.38
HDAC8 Q9BY41 1/20 0.38
NCOR2 Q9Y618 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Lithium Ion SCHEMBL17417854 0.90 HPGD (0.39) MGLLMMP2MMP9POLBHSD11B1
SCHEMBL3863463 0.90 DNM1 (0.40) MEN1KMT2ATP53SMN1; SMN2HTT
SCHEMBL308412 0.90 DNM1 (0.40) MEN1KMT2ATP53SMN1; SMN2HTT
SCHEMBL810136 0.90 DNM1 (0.40) MEN1KMT2ATP53SMN1; SMN2HTT
SCHEMBL308300 0.90 DNM1 (0.40) MEN1KMT2ATP53SMN1; SMN2HTT
SCHEMBL21810697 0.88 DNM1 (0.39) MEN1KMT2ATP53SMN1; SMN2HTT
SCHEMBL21810704 0.88 DNM1 (0.39) MEN1KMT2ATP53SMN1; SMN2HTT
SCHEMBL21810713 0.88 DNM1 (0.39) MEN1KMT2ATP53SMN1; SMN2HTT
Biphenyl SCHEMBL7784630 0.88 CYP1A2 (0.44) MGLLMMP2MMP9CYP1A2GAA
SCHEMBL4532567 0.88 LTA4H (0.38) HSD11B1MEN1KMT2ATP53SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10001703-B2 Photopolymer formulation for production of holographic media comprising borates with low TG COVESTRO DEUTSCHLAND AG (DE) 2018-06-19 US disclosed
US-10001703-B2 Photopolymer formulation for production of holographic media comprising borates with low TG COVESTRO DEUTSCHLAND AG (DE) 2018-06-19 US disclosed
EP-3058423-B1 PHOTOPOLYMER FORMULATION FOR PRODUCING HOLOGRAPHIC MEDIA WITH LOW TG BORATES COVESTRO DEUTSCHLAND AG (DE) 2018-04-18 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10001703-B2 Photopolymer formulation for production of holographic media comprising borates with low TG PTGIS, TST, MACF1 MGLL 560/4885MMP2 3291/4885MMP9 2917/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.